haloperidol has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
Excerpt | Relevance | Reference |
---|---|---|
"Two female Caucasian acute promyelocytic leukemia patients aged 46 and 56 years developed delirium during their induction treatment with all-trans retinoic acid and idarubicin." | 3.79 | Delirium in acute promyelocytic leukemia patients: two case reports. ( Ambrosio, M; Cavallari, M; Cibien, F; Cuneo, A; Daghia, G; Formigaro, L; Lista, E; Martinelli, S; Pizzolato, M; Rigolin, GM; Sofritti, O, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rigolin, GM | 1 |
Martinelli, S | 1 |
Formigaro, L | 1 |
Cibien, F | 1 |
Lista, E | 1 |
Cavallari, M | 1 |
Ambrosio, M | 1 |
Pizzolato, M | 1 |
Daghia, G | 1 |
Sofritti, O | 1 |
Cuneo, A | 1 |
1 other study available for haloperidol and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
Delirium in acute promyelocytic leukemia patients: two case reports.
Topics: Antineoplastic Agents; Antipsychotic Agents; Delirium; Female; Haloperidol; Humans; Idarubicin; Leuk | 2013 |